The reliable supply of raw materials is critical for developing successful cell and gene therapies. While the cell and gene therapy industry has made strides to ensure regulatory compliance and patient safety, the challenges surrounding scalability and consistency of raw materials remain. Often, GMP-compliant raw materials either do not currently exist or are only available “off the shelf”. Any required in-house modifications to these materials increase the possibility of user error and add complexity when scaling up the process.
This webinar will showcase how customization at the raw material level enables cell therapy manufacturers to be confident in the security of their supply, de-risk manufacturing processes, and improve their scalability.
In the first segment of this webinar, we will discuss case studies that highlight the impact of customization on successful manufacturing processes. The second segment of the webinar will focus on a discussion related to how the right suppliers can fit products to manufacturers’ process to help expedite the path to commercialization.
Attendees will learn: